STAAR Surgical Generates $464,000 in Cash from Operations During Thi...(o fund a restricted deposit to secure po...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
Date:11/2/2009
o fund a restricted deposit to secure potential payment of the judgment in the Parallax case subject to our pending appeal.
Conference Call
The Company will host a conference call and webcast on Tuesday, November 3, 2009 at 10:00 a.m. Eastern Time to discuss the Company's third quarter and current corporate developments. The dial-in number for the conference call is 877-941-2927 for domestic participants and 480-629-9725 for international participants.
A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4169709#. To access the live webcast of the call, go to STAAR Surgical's website at www.staar.com. An archived webcast will also be available at www.staar.com.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 50 countries. Collamer® is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at
| SOURCE STAAR Surgical Company Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
7. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
10. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
Post Your Comments:
(Date:12/16/2009)... ALTO, Calif., Dec. 16 The Boards ... Corporation are delighted to announce the merger of ... the field of RNAi (RNA interference). The ... have multiple RNAi discovery, development and delivery technologies, ... a broad portfolio of intellectual property. ,, ...
(Date:12/16/2009)... CHICAGO, Dec. 16 Advanced Life Sciences ... positive top-line results from a pivotal, non-human primate ... (cethromycin) against an inhaled lethal dose of tularemia. ... survival rate at the doses tested. All ... received 16 mg/kg once-a-day of Restanza (approximate to ...
(Date:12/15/2009)... SAN DIEGO, Dec. 15 Volcano Corporation ... precision intravascular therapy guidance tools - including Fractional ... IVUS and Optical Coherence Tomography (OCT) - designed ... and peripheral vascular disease, announced today the placement ... The s5 family of consoles was first launched ...
Breaking Medicine Technology:Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 3Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 4Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 1Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 2Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 3Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 4Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 1Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 2Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 4Stryker Statement in Response to the Indictment of Its Biotech Division 14634 1Stryker Statement in Response to the Indictment of Its Biotech Division 14634 2... Lenetix Announces Successful Study of Improved Non-invasive Test ... announced a significant step in the development of ... chromosomal screening test to detect Down syndrome and ... results at the 29th annual Society for Maternal-Fetal ...
... Cancer Caucus on Capitol Hill to Raise Awareness of ... 28 A group of radiation oncology ... awareness about one of the least understood cancer treatments: ... patients receive radiation treatment. In a patient,s personal ...
Other Medicine Technology:Breakthrough in Prenatal Screening for Down Syndrome 2Winning the War on Cancer: The Critical Role of Radiation Oncology 2Winning the War on Cancer: The Critical Role of Radiation Oncology 3(Date:12/16/2009)... 16 Shoppers like knowing if their ... Argentina. But grocers have found it burdensome to ... laws requiring them to provide the information at ... easyCOOLnow.com for easily making grocery and ... provisions that require retailers of unprocessed fruits, vegetables ...
(Date:12/16/2009)... MassMutual,s Retirement Services Division has announced ... platform in Q2 2010. The new platform will ... investment change materials in a variety of themes. ... from a menu of creative options to support ... population. The new RetireSmart participant engagement platform will ...
(Date:12/16/2009)... Boston University School of Medicine,s (BUSM) Pulmonary ... from the National Heart, Lung, and Blood Institute ... patients with lung disease. , Darrell Kotton, ... Gustavo Mostoslavsky, MD, PhD, assistant professor of medicine, ... award. Together Kotton and Mostoslavsky lead a multicenter ...
(Date:12/16/2009)... healthcare staffing agency, is honored to announce that Chris Wepfer ... of the Year in Healthcare Traveler magazine’s 2009 Recruiters of ... Chris has received such honors and the first for Jackie. ... ... -- Medical Solutions, a national healthcare staffing agency, is honored ...
(Date:12/16/2009)... International, Inc. (OTC Bulletin Board: MZEI) ... Board of Medizone New Zealand Ltd., a joint ... 50% interest, agreed on December 14, 2009 to ... International all global marketing rights of the company,s ... Marshall said, "Time has eroded the relevance of ...
Breaking Medicine News(10 mins):Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2[0] New Website Helps Grocers Comply With COOL Laws[0] MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform[0] Boston University School of Medicine's pulmonary center receives $1.4 million grant[0] Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients [0] Medizone International, Inc. Approves Repurchase of Global Marketing Rights
... of German and American researchers have used enetic engineering ... to transmit malaria--at least to mice, new study findings ... right direction" towards combating malaria in humans, study author ... Ohio. "We now know it is possible to genetically ...
... who suffer from premenstrual syndrome, or PMS. A new ... who have exhausted all other medications without help.// ... in Philadelphia, set out to determine whether half-cycle dosing ... started 14 days prior to the start of menstruation. ...
... vitamins may not play a role in preventing death ... believe vitamin intake could prevent cardiovascular disease, but results ... University Hospital in Switzerland and University of Miami School ... if vitamin E, vitamin C or a multivitamin could ...
... biting a bar of chocolate every day is connected to ... fat and sugar, it has long been seen as a ... based products, it also contains antioxidants, which can protect from ... now suggest that people who eat chocolate regularly are happier ...
... According to researchers, women who have had a complicated ... heart disease later on. Researchers in Glasgow, Scotland, suggest ... difficult pregnancies //- for they are at risk of ... who develop diabetes during pregnancy are at increased risk ...
... on the hazards faced during travel. People travelling in the US ... posed by outdoor adventure. Many travel experts expect people to holiday ... //An outdoor adventure holiday with lots of wildlife and sports ... hazards involved in this kind of trip, say experts at the ...
Other Medicine News:Health News: Gene researchers make Malaria-resistant mosquito 2Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Micro emulsifying needles, 18G....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
... forceps "micro 2000", with ... tension light-weight instruments with ... extremely light weight, well ... fatigueless working, easy to ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |